Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids
NCT ID: NCT02298452
Last Updated: 2016-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
253 participants
INTERVENTIONAL
2013-05-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality Control of CE-Certified Phonak Hearing Aids - 2019_23
NCT04048187
Quality Control of CE-Certified Phonak Hearing Aids - 2016_05
NCT02951247
Quality Control of CE-Certified Phonak Hearing Aids - 2020_43
NCT04723173
Quality Control of CE-Certified Phonak Hearing Aids - 2017_27
NCT03253003
Quality Control of CE-Certified Phonak Hearing Aids - 2016_37
NCT03108768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hearing aid
172 subjects with a mild hearing loss. 140 subjects with a moderate hearing loss. 70 subjects with a severe/ profound hearing loss.
Hearing aid.
The hearing aid will be fitted to the individual hearing loss of the subject.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hearing aid.
The hearing aid will be fitted to the individual hearing loss of the subject.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all kinds of hearing loss (flat, sloping) which are in the fitting range of the hearing aids
* mother tongue (swiss) german
Exclusion Criteria
* with a reduced mobility unable to attend weekly study appointments
* without access to a number of different hearing situations
* with strongly reduced ability to describe auditory impressions and the usage of the hearing aids
* which are uncooperative so that it is not possible to record a valid pure tone audiogram
* with a strongly reduced dexterity
* with psychological problems
* central hearing disorders
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Phonak AG, Switzerland
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone Ebbing, B. Sc.
Role: PRINCIPAL_INVESTIGATOR
Phonak AG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Phonak AG
Stäfa, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KEK 2013-0144
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.